Matthew J. Johnson

Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.

Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease.

Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors.

Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors.

CRISPR/Cas9-Mediated Genome Engineering of Primary Human B Cells.

mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation.

Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.

A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes.

Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair.

Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders.

Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapy.

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial.